Compare Corning Incorporated (GLW) vs 10X Genomics Inc (TXG) Price & Performance

Corning (GLW) trades at $163.21, down 3.41% today, but maintains a bullish technical outlook with strong support at $160. The company recently secured a significant $3 billion fiber supply agreement with AT&T, boosting growth prospects in the AI infrastructure sector. Despite elevated valuation ratios (P/E 75.23), GLW has consistently beaten earnings estimates in recent quarters, with Q3 2026 EPS expected at $0.878. Operating cash flow improved to $2.7 billion in 2025, supporting the company's dividend payments and strategic investments.

GLW presents a compelling growth story driven by AI infrastructure demand, with analyst consensus favoring Buy ratings (56.75%) and a $171.25 price target offering 5% upside. Key risks include patent litigation concerns and the stock's premium valuation requiring sustained earnings growth. The AT&T partnership positions Corning to capitalize on expanding fiber optic needs, though investors should monitor competitive pressures and execution risks in the rapidly evolving technology sector.

10x Genomics (TXG) trades at $76.10, down 5.65% on the day, as technical indicators signal bearish momentum with the stock below key resistance levels. The company shows improving fundamentals with three consecutive quarterly earnings beats and positive operating cash flow of $136M in 2025, though it remains unprofitable with a -12.18% net margin. Recent developments include the launch of Atera spatial biology platform shipments and a patent victory against Parse Biosciences.

TXG presents a mixed investment case with strong product innovation and improving financial trends offset by high valuation metrics and persistent losses. The stock's risk/reward appears balanced near analyst consensus targets, requiring successful execution on Atera commercialization and path to profitability to justify current multiples.